The expansion adds obesity-focused services through partnerships with five providers spanning GLP-1 use around fitness, nutrition, coaching, telehealth, and personalized insights
Studies show that patients who are obese or overweight using injectable GLP-1 agonist medications for weight loss, combined with diet and exercise, achieve weight loss of approximately 6% of their body weight at 4 months, 9% at 6 months, and 13% at 12 months
Is weight loss a part of your New Years resolution
Ozempic works by first lowering blood sugar levels and then combining a slowing down of digestion with a reduction in appetite to achieve weight loss
Additionally, watch for unusual side effects such as excessive drowsiness, worsening gastrointestinal symptoms, or changes in sleep quality, and report any concerns to your healthcare provider